## **Core Concept**
The question pertains to a patient with leukemia who develops respiratory symptoms, including chest pain, pulmonary infiltrates, and pleural effusion, likely due to a complication of their treatment. This scenario suggests an adverse effect related to chemotherapy or radiation therapy.

## **Why the Correct Answer is Right**
The correct answer, **Bleomycin-induced pulmonary toxicity**, is a well-known side effect of certain chemotherapeutic agents, particularly bleomycin, which is used in the treatment of various cancers, including leukemia, lymphoma, and testicular cancer. Bleomycin can cause pulmonary fibrosis, which presents with symptoms such as chest pain, pulmonary infiltrates, and pleural effusion. The mechanism involves the generation of reactive oxygen species that damage lung tissue.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include other causes of respiratory distress that are less directly related to chemotherapy side effects.
- **Option B:** Similarly, without the specific text, we can infer that any option not directly related to chemotherapy-induced lung injury would be incorrect.
- **Option C:** Again, without specifics, any alternative cause not directly linked to the side effect profile of leukemia treatment would not be correct.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **bleomycin-induced pulmonary toxicity** is a dose-dependent side effect, and monitoring lung function tests is crucial in patients receiving bleomycin. The toxicity can be irreversible and is a significant concern in the management of patients with cancer.

## **Correct Answer: B. Bleomycin-induced pulmonary toxicity**